BR8807376A - Microorganismo atenuado,composicao farmaceutica e processo de produzir um microorganismo atenuado - Google Patents
Microorganismo atenuado,composicao farmaceutica e processo de produzir um microorganismo atenuadoInfo
- Publication number
- BR8807376A BR8807376A BR888807376A BR8807376A BR8807376A BR 8807376 A BR8807376 A BR 8807376A BR 888807376 A BR888807376 A BR 888807376A BR 8807376 A BR8807376 A BR 8807376A BR 8807376 A BR8807376 A BR 8807376A
- Authority
- BR
- Brazil
- Prior art keywords
- attenued
- microorganism
- producing
- pharmaceutical composition
- organisms
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 229940031348 multivalent vaccine Drugs 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878730037A GB8730037D0 (en) | 1987-12-23 | 1987-12-23 | Vaccines |
| PCT/GB1988/001143 WO1989005856A1 (en) | 1987-12-23 | 1988-12-22 | Vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR8807376A true BR8807376A (pt) | 1990-03-20 |
Family
ID=10628973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR888807376A BR8807376A (pt) | 1987-12-23 | 1988-12-22 | Microorganismo atenuado,composicao farmaceutica e processo de produzir um microorganismo atenuado |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0322237B1 (pt) |
| JP (1) | JP2602970B2 (pt) |
| KR (1) | KR970010759B1 (pt) |
| AT (1) | ATE103331T1 (pt) |
| AU (1) | AU619519B2 (pt) |
| BR (1) | BR8807376A (pt) |
| CA (1) | CA1327331C (pt) |
| DE (1) | DE3888652T2 (pt) |
| DK (1) | DK174952B1 (pt) |
| ES (1) | ES2061700T3 (pt) |
| GB (1) | GB8730037D0 (pt) |
| HK (1) | HK1000469A1 (pt) |
| HU (2) | HUT55242A (pt) |
| IE (1) | IE65176B1 (pt) |
| IL (1) | IL88766A (pt) |
| MY (1) | MY104367A (pt) |
| NZ (1) | NZ227472A (pt) |
| PH (1) | PH31428A (pt) |
| RU (1) | RU2114172C1 (pt) |
| WO (1) | WO1989005856A1 (pt) |
| ZA (1) | ZA889605B (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU626139B2 (en) * | 1989-01-12 | 1992-07-23 | Commonwealth Scientific And Industrial Research Organisation | Avirulent salmonella vaccine |
| IE61635B1 (en) * | 1990-03-13 | 1994-11-16 | Trinity College Dublin | Improvements in vaccines |
| GB9007194D0 (en) * | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
| PL170938B1 (pl) * | 1991-03-05 | 1997-02-28 | Wellcome Found | Sposób wytwarzania szczepionki przeciwko infekcjom Salmonella PL PL |
| TW201794B (pt) * | 1991-05-03 | 1993-03-11 | American Cyanamid Co | |
| CA2156191A1 (en) * | 1993-02-22 | 1994-09-01 | Stephen B. Calderwood | Heterologous antigens in live cell vaccine strains |
| US6036953A (en) * | 1996-11-29 | 2000-03-14 | The General Hospital Corporation | Heterologous antigens in live cell V. cholerae strains |
| GB9711964D0 (en) * | 1997-06-09 | 1997-08-06 | Medical Res Council | Live attenuated vaccines |
| EP1012232B1 (en) | 1997-09-10 | 2009-10-28 | Vion Pharmaceuticals, Inc. | Genetically modified tumor-targeted bacteria with reduced virulence |
| US6080849A (en) | 1997-09-10 | 2000-06-27 | Vion Pharmaceuticals, Inc. | Genetically modified tumor-targeted bacteria with reduced virulence |
| EP0913480A3 (en) * | 1997-11-03 | 2001-07-11 | Smithkline Beecham Corporation | Chorismate synthase |
| US6905691B1 (en) | 1997-12-11 | 2005-06-14 | Celltech Pharma Europe Limited | Vaccines containing attenuated bacteria |
| GB9806449D0 (en) | 1998-03-25 | 1998-05-27 | Peptide Therapeutics Ltd | Attenuated bacteria useful in vaccines |
| US6962696B1 (en) | 1999-10-04 | 2005-11-08 | Vion Pharmaceuticals Inc. | Compositions and methods for tumor-targeted delivery of effector molecules |
| GB0121998D0 (en) | 2001-09-11 | 2001-10-31 | Acambis Res Ltd | Attenuated bacteria useful in vaccines |
| JP4623625B2 (ja) | 2003-07-24 | 2011-02-02 | 株式会社ＡＭＢｉＳ | ヘテロ型５量体組換えワクチン |
| FR2898276B1 (fr) * | 2006-03-08 | 2008-07-25 | Univ Claude Bernard Lyon | Nouveaux vaccins destines au traitement ou a la prevention des infections par parasites de la famille des taenidae et en particulier du genre echinococcus |
| BR112013015009B1 (pt) * | 2010-12-22 | 2020-11-10 | Intervet International B.V | vacina para proteger um animal contra uma doença clínica decorrente de uma infecção com bordetella bronchiseptica |
| WO2012123269A1 (en) | 2011-03-11 | 2012-09-20 | Proyecto De Biomedicina Cima, S.L. | Immunogenic compositions and methods for their use |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4337314A (en) * | 1979-05-23 | 1982-06-29 | Research Corporation | Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype |
| US4735801A (en) * | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
-
1987
- 1987-12-23 GB GB878730037A patent/GB8730037D0/en active Pending
-
1988
- 1988-12-22 HU HU89702A patent/HUT55242A/hu unknown
- 1988-12-22 JP JP1501160A patent/JP2602970B2/ja not_active Expired - Lifetime
- 1988-12-22 IL IL8876688A patent/IL88766A/en unknown
- 1988-12-22 CA CA000586868A patent/CA1327331C/en not_active Expired - Lifetime
- 1988-12-22 BR BR888807376A patent/BR8807376A/pt not_active Application Discontinuation
- 1988-12-22 MY MYPI88001526A patent/MY104367A/en unknown
- 1988-12-22 ZA ZA889605A patent/ZA889605B/xx unknown
- 1988-12-22 ES ES88312203T patent/ES2061700T3/es not_active Expired - Lifetime
- 1988-12-22 DE DE3888652T patent/DE3888652T2/de not_active Expired - Lifetime
- 1988-12-22 IE IE383988A patent/IE65176B1/en not_active IP Right Cessation
- 1988-12-22 AU AU29193/89A patent/AU619519B2/en not_active Expired
- 1988-12-22 KR KR1019880017199A patent/KR970010759B1/ko not_active IP Right Cessation
- 1988-12-22 HU HU89702A patent/HU216449B/hu unknown
- 1988-12-22 AT AT88312203T patent/ATE103331T1/de not_active IP Right Cessation
- 1988-12-22 PH PH37971A patent/PH31428A/en unknown
- 1988-12-22 RU SU4742131A patent/RU2114172C1/ru active
- 1988-12-22 NZ NZ227472A patent/NZ227472A/en unknown
- 1988-12-22 WO PCT/GB1988/001143 patent/WO1989005856A1/en unknown
- 1988-12-22 EP EP88312203A patent/EP0322237B1/en not_active Expired - Lifetime
-
1989
- 1989-08-22 DK DK198904126A patent/DK174952B1/da not_active IP Right Cessation
-
1997
- 1997-10-15 HK HK97101924A patent/HK1000469A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB8730037D0 (en) | 1988-02-03 |
| KR890010200A (ko) | 1989-08-07 |
| ES2061700T3 (es) | 1994-12-16 |
| DK412689D0 (da) | 1989-08-22 |
| ATE103331T1 (de) | 1994-04-15 |
| DE3888652D1 (de) | 1994-04-28 |
| ZA889605B (en) | 1990-08-29 |
| HUT55242A (en) | 1991-05-28 |
| JPH02502785A (ja) | 1990-09-06 |
| WO1989005856A1 (en) | 1989-06-29 |
| AU2919389A (en) | 1989-07-19 |
| DK174952B1 (da) | 2004-03-22 |
| HU890702D0 (en) | 1991-01-28 |
| EP0322237A1 (en) | 1989-06-28 |
| MY104367A (en) | 1994-03-31 |
| DK412689A (da) | 1989-08-22 |
| EP0322237B1 (en) | 1994-03-23 |
| PH31428A (en) | 1998-11-03 |
| IE65176B1 (en) | 1995-10-04 |
| RU2114172C1 (ru) | 1998-06-27 |
| HU216449B (hu) | 1999-06-28 |
| JP2602970B2 (ja) | 1997-04-23 |
| HK1000469A1 (en) | 1998-03-27 |
| DE3888652T2 (de) | 1994-07-07 |
| AU619519B2 (en) | 1992-01-30 |
| IE883839L (en) | 1989-06-23 |
| KR970010759B1 (ko) | 1997-06-30 |
| CA1327331C (en) | 1994-03-01 |
| NZ227472A (en) | 1992-07-28 |
| IL88766A (en) | 1995-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR8807376A (pt) | Microorganismo atenuado,composicao farmaceutica e processo de produzir um microorganismo atenuado | |
| GR3017535T3 (en) | Live vaccines. | |
| DE3280019D1 (en) | Vaccines, a method for making vaccines and a method for stimulating antibody production | |
| FI101632B1 (fi) | Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä | |
| ATE106748T1 (de) | Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum. | |
| HUT46858A (en) | Process for producing vaccine against coronavirus of dogs | |
| DE69132417T2 (de) | Impfstoff gegen die Lyme-Krankheit | |
| DE3888290D1 (de) | Mutanten des infektiösen bovinen Rhinotracheitisvirus, Vakzine die sie enthalten, Verfahren zu ihrer Herstellung und ihrer Verwendung. | |
| DE2962920D1 (en) | Attenuated strain of feline infectious peritonitis virus, method for preparing it and vaccine comprising it | |
| ATE61230T1 (de) | Verfahren zur herstellung einer keuchhustenimpfstoffkomponente und kombinierter impfstoff,bestehend aus keuchhustenantigen diphterietoxoid und tetanustoxoid. | |
| DK145988D0 (da) | Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse | |
| IL67818A0 (en) | Vaccines comprising ozone inactivated organisms and their production | |
| DE3484989D1 (de) | Unikale, monogenetische streptokinase, ihre herstellung und verwendung. | |
| FR2580176B1 (fr) | Vaccin antirabique avirulent | |
| IT1213613B (it) | Processo industriale per la fabbricazione di quadretti conteneti una foto-ricordo per tombe o pietre sepolcrali | |
| ATE105022T1 (de) | Herstellung von 2-desoxyuridin. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Decision: refusal |